Last update 09 Aug 2025

EGFR antagonists(TargImmune Therapeutics)

Overview

Basic Info

Drug Type
Oligonucleotide
Synonyms-
Target
EGFR
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
EGFR positive Neoplasms
Inactive Indication-
Originator Organization
Targimmune Therapeutics AGTargimmune Therapeutics AG
Active Organization
Targimmune Therapeutics AGTargimmune Therapeutics AG
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

100 Clinical Results associated with EGFR antagonists(TargImmune Therapeutics)
Login to view more data
100 Translational Medicine associated with EGFR antagonists(TargImmune Therapeutics)
Login to view more data
100 Patents (Medical) associated with EGFR antagonists(TargImmune Therapeutics)
Login to view more data
27
Literatures (Medical) associated with EGFR antagonists(TargImmune Therapeutics)
01 Jan 2025The Gulf journal of oncology
Short communication | Hallmarks of Cancer; A Summarized Overview of Sustained Proliferative Signalling Component.
01 Jun 2024Dermatologie (Heidelberg, Germany)
Drug-related exanthema under immunotherapy and targeted oncological therapy
01 Jan 2024Journal of pharmaceutical and biomedical analysis
Application of SNAP-tag-EGFR cell membrane chromatography model in screening antitumor active components of Silybum marianum (L.) Gaertn
100 Deals associated with EGFR antagonists(TargImmune Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EGFR positive NeoplasmsPreclinical
Switzerland
Targimmune Therapeutics AGTargimmune Therapeutics AG
22 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free